#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia Growth hormone deficiency Hypersensitivity pneumonitis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Heart disease congenital Erythema Juvenile psoriatic arthritis Conjunctivitis allergic Anti-myelin-associated glycoprotein antibodies positive Immunodeficiency common variable Infective uveitis Neutropenia Urea cycle disorder Epstein-Barr virus infection Soft tissue necrosis More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Diagnostics Advanced systemic mastocytosis – Diagnostics CADASIL – Treatment IgA nephropathy – Basic Information Glomerulonephritis membranoproliferative – Treatment Carcinoid syndrome – Basic Information Burkitt’s lymphoma – Diagnostics Ocular melanoma – Life with Disease Methylmalonic acidaemia – Basic Information Sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gabapentin Co-Trimoxazole FRUQUINTINIB Abc-31-116 Valproic Acid Exemestane Pitolisant Romidepsin Capsaicin Xtmab-16 Omp12 Busulfan Keto-Leucine Calcium ENSIFENTRINE Zolbetuximab L-Ascorbic Acid Enx-101 Lanifibranor Rasburicase Oxygen More therapies…

    Learn about Your Condition

    Colorectal adenocarcinoma Oropharyngeal cancer Essential thrombocythaemia Urea cycle disorder Cutaneous T-cell lymphoma Seasonal allergy Microscopic polyangiitis Lung transplant Renal failure Mite allergy Alport's syndrome Cardiac failure acute Vulvovaginal candidiasis Chondropathy Affective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Pain Relief in Hip Replacement Surgery Using Ropivacaine and Adrenaline for Patients Undergoing Total Hip Arthroplasty

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride
    The Netherlands

  • Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Exemestane
    • Everolimus
    Hungary

  • Study on the Safety and Effectiveness of Regorafenib for Patients with Arterio-Venous Malformations Unresponsive to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Regorafenib
    Belgium

  • Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Olaparib
    The Netherlands

  • Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ANTI-GD2-800CW
    The Netherlands

  • Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Nephroblastoma
    • Rhabdoid tumour
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain
Previous Page
1 … 813 814 815 816 817 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!